Who owns Magenta Therapeutics Inc?
- Ticker: MGTA
- CUSIP Number: 55910k108
Tip: Access positions for across all investors
Analyze quarterly positions in Magenta Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Magenta Therapeutics stock
Who bought or sold Magenta Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tang Capital Management | 6.1M | $4.6M | 0% | Jun 2023 |
|
| Nantahala Capital Management | 5.0M | $3.8M | 100% | Jun 2023 |
|
| Atlas Venture Life Science Advisors | 3.8M | $2.9M | 0% | Jun 2023 |
|
| Citadel Advisors | 3.4M | $2.6M | 10919% | Jun 2023 |
|
| Alphabet | 3.3M | $2.5M | 0% | Jun 2023 |
|
| Vanguard Group | 2.0M | $1.5M | 0% | Jun 2023 |
|
| Laurion Capital Management | 582k | $441k | 0% | Jun 2023 |
|
| Octagon Capital Advisors | 550k | $417k | 100% | Jun 2023 |
|
| Renaissance Technologies | 482k | $365k | 22% | Jun 2023 |
|
| Acadian Asset Management | 458k | $346k | -25% | Jun 2023 |
|
| Verition Fund Management | 378k | $287k | -83% | Jun 2023 |
|
| BlackRock | 364k | $276k | -22% | Jun 2023 |
|
| Geode Capital Management | 358k | $271k | 0% | Jun 2023 |
|
| Harvard Management Company | 333k | $252k | 0% | Jun 2023 |
|
| Rbf Capital | 251k | $190k | 0% | Jun 2023 |
|
| Bessemer | 237k | $180k | 0% | Jun 2023 |
|
| Two Sigma Advisers | 177k | $135k | 15% | Jun 2023 |
|
| Harbor Capital Advisors | 168k | $127k | 10% | Jun 2023 |
|
| Credit Suisse | 149k | $113k | -23% | Jun 2023 |
|
| State Street Corporation | 139k | $106k | 0% | Jun 2023 |
|
| Two Sigma Investments | 120k | $91k | 32% | Jun 2023 |
|
| Susquehanna International | 103k | $78k | -43% | Jun 2023 |
|
| Corsair Capital Management | 100k | $76k | 204% | Jun 2023 |
|
| Northern Trust | 72k | $54k | -27% | Jun 2023 |
|
| Bank of New York Mellon | 60k | $46k | -8% | Jun 2023 |
|
| Cheyne Capital Management | 47k | $36k | 0% | Jun 2023 |
|
| Fiduciary Trust Company | 31k | $23k | 0% | Jun 2023 |
|
| Bank of America Corporation | 28k | $21k | -1% | Jun 2023 |
|
| Charles Schwab Investment Management | 27k | $21k | 0% | Jun 2023 |
|
| XTX Topco | 27k | $20k | 100% | Jun 2023 |
|
| Morgan Stanley | 17k | $13k | -79% | Jun 2023 |
|
| Tower Research Capital | 12k | $9.2k | -8% | Jun 2023 |
|
| UBS Group | 11k | $8.5k | 300% | Jun 2023 |
|
| Sound View Wealth Advisors Group | 11k | $8.0k | 0% | Jun 2023 |
|
| Rathbones Brothers | 10k | $7.6k | 0% | Jun 2023 |
|
| Royal Bank of Canada | 5.8k | $0 | 9% | Jun 2023 |
|
| Bnp Paribas Arbitrage, Snc | 4.5k | $3.4k | -8% | Jun 2023 |
|
| Wells Fargo & Company | 779.00 | $591.105200 | 2% | Jun 2023 |
|
| Umb Bank N A | 742.00 | $561.990800 | 0% | Jun 2023 |
|
| Jpmorgan Chase & Co | 703.00 | $533.014600 | 0% | Jun 2023 |
|
| Hanson McClain Advisors | 375.00 | $285.000000 | 0% | Jun 2023 |
|
| Barclays | 52.00 | $0 | 0% | Jun 2023 |
|
| Institutional & Family Asset Management | 50.00 | $38.000000 | 0% | Jun 2023 |
|
| Simplex Trading | 16.00 | $0 | -100% | Jun 2023 |
|
Who sold out of Magenta Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Lion Point Capital | Mar 2023 | 4.6M | $3.6M |
| Western Standard | Mar 2023 | 1.4M | $1.1M |
| TCW Group | Mar 2023 | 750k | $596k |
| Marshall Wace | Mar 2023 | 158k | $125k |
| Bridgeway Capital Management | Mar 2023 | 153k | $121k |
| National Asset Management | Mar 2023 | 14k | $11k |
| Virtu Financial | Mar 2023 | 11k | $9.0k |
| Belpointe Asset Management | Mar 2023 | 5.5k | $4.4k |
| Citigroup | Dec 2022 | 737.00 | $290.967600 |
| FMR | Mar 2023 | 254.00 | $202.006200 |